News + Font Resize -

Aurobindo's amlodipine besylate tabs gets US FDA nod
Our Bureau, Mumbai | Friday, July 20, 2007, 08:00 Hrs  [IST]

Aurobindo Pharma Ltd has received approval from the US FDA for amlodipine besylate tablets 2.5 mg, 5 mg and 10 mg. This is the company's fifth anti-hypertensive approval from US FDA.

Amlodipine besylate tablets 2.5 mg; 5 mg and 10 mg are the generic equivalent of Pfizer's Norvasc tablets and are indicated for the treatment of hypertension. The brand product has approximately annual sales of USD 2.8 billion.

Post Your Comment

 

Enquiry Form